Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. The search included studies through 11-May-2020. Eight studies were included, all of which are randomized controlled trials.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Veriheal

NOVEMBER 21, 2023

Veriheal remains dedicated to supporting the next generation of pioneers through its Innovation in Cannabis Scholarship. This year, we are proud to continue our investment in the next generation of cannabis industry leaders. Their one-of-a-kind innovations and solutions are invaluable to the future of cannabis.

Research and Development 106

Research and Development Consumption Education Data 106

WeedAdvisor

JULY 21, 2019

The Financial Times also points out how Colombia’s advantages – cheap labour, better climate and plenty of experienced workers – help keep prices down and give the Colombian cannabis industry its competitive edge. Their ability to follow them will ultimately decide the Colombian cannabis industry’s fate. A Bombardment of Investors. .

Conditions 60

Conditions Seed-To-Sale Compliance Compliance 60

Cannabis Law Report

NOVEMBER 14, 2019

Survey of more than 10,000 people by the Centre for Medicinal Cannabis shows might higher incidence than previously thought reports inews UK. million adults are now using “street cannabis ” to treat the symptoms of chronic conditions , according to the largest poll of its kind. They write. New guidelines.

Conditions 45

Conditions Data Medicine Collective 45

Veriheal

MAY 19, 2023

Washington cannabis consumers gained new employment protections, a study investigated how psilocybin can help folks with color blindness, and ketamine is having its heyday. Washington State Bulks Up Cannabis-Employment Rights Washington cannabis consumers, rejoice! Let’s dive into this week’s canna-news!

Chronic Pain 94

Chronic Pain Data Consumption Safety 94

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

The Cannigma

OCTOBER 6, 2022

Getting the right answers in your cannabis journey can be tricky. But with The Cannigma’s Ask the Expert, you can find questions from readers like you, answered by a real cannabis pharmacist. Cannabis smoke (and vaping and dabbing) has been associated with bronchitis (aka inflammation of the airways). Question: Hello.

Vaping 90

Vaping Topical Data Safety 90

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of the patients reported pain as their primary motivation for obtaining a medicinal cannabis prescription. years between May 2015 and October 2018. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

MAY 16, 2022

Data on injured workers from the nation’s most mature adult-use cannabis market is pretty boring. It has been 10 years since Colorado legalized recreational cannabis, and 22 years following legalization of medicinal use. However, April was traditionally the safest month for cannabis workers.

Data 52

Data Strains Safety Cultivation 52

Veriheal

JANUARY 16, 2024

As the natural remedy of cannabis gains more widespread acceptance and products become increasingly available, its healing properties are slowly gaining acceptance into mainstream culture. A remarkable observation from the study was the overwhelmingly positive safety profile of CBD as a treatment option.

Patients 113

Patients CBD Treatment Research and Development 113

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. THC is a naturally occurring cannabinoid produced by the cannabis plant. million individuals in the U.S.

Clinical Trials 52

Clinical Trials Data Patients THC 52

The Cannigma

DECEMBER 20, 2021

Oils, creams, skin balms, gels and serums made from cannabis come in all shapes and sizes, and many of these products promise to improve your skin and make it healthier. But how does cannabis actually affect the skin? Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

Cannabis Law Report

AUGUST 27, 2021

On August 19, 2021, the New Jersey Cannabis Regulatory Commission (CRC) approved the Specially Adopted Personal Use Cannabis Rules (the “Rules”). The Rules establish the recreational cannabis industry in New Jersey and allow the CRC to begin licensing businesses as soon as possible.

Cultivation 105

Cultivation Conditions Business Cannabis 105

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Veriheal

NOVEMBER 18, 2022

A pair of boxing legends teamed up for an unexpected collaboration, Texas’ medical cannabis program saw big gains, and a hemp study revealed troubling signs for the industry. Earlier this month, we reported on the pair’s unexpected venture into the world of cannabis! Let’s dive into this week’s cannanews.

Edibles 97

Edibles Hemp Epilepsy Programs 97

Cannabis Law Report

APRIL 1, 2022

The General Council of Pharmacists has proposed this Monday to carry out a pilot test in pharmacies to assess the use of cannabis for therapeutic purposes, a product that, in the opinion of the president of pharmacists, could have a similar use and conditions of use to those that have other compounds such as morphine.

Medicine 52

Medicine Data Safety Conditions 52

Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 64

Safety Food CBD Oil 64

Cannabis Law Report

AUGUST 16, 2022

The New York State Cannabis Control Board (“CCB”) approved 15 Adult-Use Conditional Processor (“AUCP”) licenses during its public meeting today, adding a key link in the state’s budding adult-use cannabis supply chain. The application window for the adult-use cannabis conditional cultivator licenses closed on June 30, 2022.

Supply Chain 52

Supply Chain Conditions Cannabinoids Programs 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 109

Consumption Patients Research and Development Data 109

Veriheal

DECEMBER 23, 2022

Cannabis prohibition is doing more than just creating a barricade between consumers and safe products. State Cannabis Contaminant Rules Vary Widely,” consumers have little choice but to purchase contaminated cannabis products. Researchers Inspected Cannabis Products for Contaminants. Led by Dr. Maxwell C.K.

Research and Development 92

Research and Development Agriculture Data Extraction 92

Cannabis Law Report

JUNE 16, 2021

As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. The State Institute for Drug Control regulates cannabis for medical use, and one must meet predetermined and rigorously controlled requirements to use or sell the plant. 50/2013 Coll.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Canna Law Blog

JANUARY 17, 2023

In November 2022, the OLCC adopted and amended a suite of cannabis rules that became effective January 1, 2023. Now that Oregon’s new cannabis rules are effective, let’s take a look at some of the important changes to the rules governing the Oregon industry. Change in business structure. Our thoughts (good and bad) are here.

Retail 71

Retail Cannabis Conditions Business 71

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. Sapphire-Pricing-and-Timelines-v1.4.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

AUGUST 16, 2021

A group of organizations and individuals led by National Advocates for Pregnant Women and including comedian Amy Schumer have weighed in on a lawsuit in support of a Phoenix woman accused of child endangerment for her legal use of cannabis during a difficult portion of her pregnancy.

Safety 116

Safety Patients Cannabis Law 116

Cannabis Law Report

AUGUST 10, 2021

This authorisation for TSC, represents the fourth approved indication of a cannabis-based medicine in the UK for GW and underlines GW’s commitment to the UK and regulatory approved cannabis-based medicines. “We The safety profile observed was consistent with findings from previous studies, with no new safety risks identified.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Veriheal

JULY 7, 2022

Cannabis can help with a whole host of conditions, but some research has raised concerns about its potentially negative impact on the heart. Cannabis Use and Heart Attacks. The study conducted by Stanford researchers found a strong association between an increased risk of heart attacks and regular cannabis use.

THC 98

THC Medicine Cannabinoids Conditions 98

The Cannigma

AUGUST 24, 2021

Long before we all got surgically-attached to our smartphones, cannabis was there, lovingly held in the palm of your hand, a constant companion in daily life. But as cannabis has become more mainstream – and our lives have become more and more online – the cannabis industry has also gone mobile. Learn More.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

MAY 26, 2022

Successful Behavioral Addiction Study Supplied Data for Patent. The successful completion of Awakn’s behavioral addictions study was announced last week and the data provided from the study was used in the patent filing. The treatment was also well tolerated with no safety concerns. Awakn Life Sciences Corp. (

Treatment 52

Treatment Research and Development Therapy Data 52

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge. We have a ways to go,” Tan said.

Education 101

Education Clinical Trials Medicine Policy 101

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. ” Dr. Gallow prides himself on his work as a South African cannabis advocate and leader in the international medical cannabis research field. It has been fairly slow,” explained Dr. Gallow.

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113